SMYD3 Modulates the HGF/MET Signaling Pathway in Gastric CancerKatia De Marco, Cristiano Simone|Cells|2023Cited by 4
Targeting the DNA-repair chromatin-modifier protein SMYD3 as a potential epigenetics-based therapy for gastric cancerKatia De Marco|IRIS Research product catalog (Sapienza University of Rome)|2026Cited by 0